Fig. 1From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agentsPredicted pIC50 versus experimental figures of the modelling and validation setBack to article page